Insider Selling: Reckitt Benckiser Group plc (LON:RKT) Insider Sells £64,610.64 in Stock

Reckitt Benckiser Group plc (LON:RKT) insider Shannon Eisenhardt sold 1,368 shares of the firm’s stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of GBX 4,723 ($59.61), for a total transaction of £64,610.64 ($81,548.20).

Reckitt Benckiser Group Price Performance

Shares of LON:RKT opened at GBX 4,857 ($61.30) on Friday. The company has a current ratio of 0.69, a quick ratio of 0.46 and a debt-to-equity ratio of 112.52. The stock has a market capitalization of £33.57 billion, a PE ratio of 2,238.25, a PEG ratio of 1.10 and a beta of 0.09. The firm has a 50 day moving average of GBX 4,785.46 and a 200-day moving average of GBX 4,525.03. Reckitt Benckiser Group plc has a 12 month low of GBX 4,034 ($50.92) and a 12 month high of GBX 5,886.44 ($74.30).

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on RKT shares. JPMorgan Chase & Co. lowered Reckitt Benckiser Group to a “neutral” rating in a report on Friday, August 30th. Berenberg Bank reduced their target price on shares of Reckitt Benckiser Group from GBX 5,200 ($65.63) to GBX 5,177 ($65.34) and set a “hold” rating for the company in a research report on Wednesday, October 23rd.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.